Pabau GO app

The new Pabau GO is heredownload on the App Store

Download on the App Store
Book a demo Book a demo
Diagnostic Codes

ICD-10 Code D43.2: Neoplasm of uncertain behavior of brain, unspecified

Key Takeaways

Key Takeaways

ICD-10 Code D43.2 describes a neoplasm of uncertain behavior of brain, unspecified, a billable ICD-10-CM code valid for all HIPAA-covered transactions from October 1, 2025.

D43.2 sits within the D43 parent category under the D37-D48 range; use it only when pathology or imaging confirms uncertain (not malignant, benign, or in-situ) behavior.

Common miscoding pitfall: defaulting to D49.6 (unspecified behavior) when the clinical record actually documents uncertain behavior, which maps to D43.2 instead.

Practice management software like Pabau provides claims management and clinical documentation tools that help coding teams attach the correct ICD-10 diagnosis code, reducing claim rework and audit exposure.

ICD-10 Code D43.2: Definition and billable status

ICD-10 Code D43.2 is a billable ICD-10-CM code for neoplasm of uncertain behavior of brain, unspecified. It applies when a pathology report or imaging note documents that a brain mass cannot be classified as malignant, benign, or in-situ, and the record does not specify whether the location is supratentorial or infratentorial.

Coders sometimes default to D49.6, the code for unspecified behavior, when the record actually documents uncertain behavior. That substitution is a common source of payer queries, since the two codes describe different levels of clinical certainty.

This reference covers the code hierarchy, sibling codes, approximate synonyms, differential coding guidance, documentation requirements, commonly paired codes, and MS-DRG reimbursement context.

D43.2 code at a glance

The table below captures the essential reference data for D43.2. Coders working against the 2026 ICD-10-CM edition should confirm these values annually, as CMS updates the tabular list each October.

Field Value
Code D43.2
Full description Neoplasm of uncertain behavior of brain, unspecified
Billable/specific Yes – valid for diagnosis reporting and reimbursement
Code system ICD-10-CM (International Classification of Diseases, 10th Revision, Clinical Modification)
Effective date October 1, 2025 (2026 edition)
HIPAA transactions Valid for all HIPAA-covered transactions
Parent category D43 – Neoplasm of uncertain behavior of brain and central nervous system
Chapter block D37-D48 – Neoplasms of uncertain behavior, polycythemia vera, and myelodysplastic syndromes

D43.2 code hierarchy

ICD-10-CM Code D43.2 occupies the third level of a three-tier hierarchy. Understanding the path from chapter to specific code matters when documentation supports a more precise sibling code versus the unspecified option.

Level Code Description
Block D37-D48 Neoplasms of uncertain behavior, polycythemia vera, and myelodysplastic syndromes
Category D43 Neoplasm of uncertain behavior of brain and central nervous system
Specific code D43.2 Neoplasm of uncertain behavior of brain, unspecified

The D43 category sits within Chapter 2 (Neoplasms, C00-D49) of the ICD-10-CM tabular list. The WHO’s ICD-10 browser confirms the international classification alignment for the D37-D48 block. Coders working in neurology and neurosurgery billing will recognize this chapter structure across the other codes in the same block.

D43.2 is the fallback code when the clinical record does not specify the brain location as supratentorial or infratentorial. Before defaulting to it, check whether the operative or imaging report provides enough anatomical detail to support a more specific sibling.

Code Description Use when
D43.0 Neoplasm of uncertain behavior of brain, supratentorial Mass documented above the tentorium cerebelli (cerebral hemispheres, frontal, parietal, temporal, occipital lobes, or ventricles)
D43.1 Neoplasm of uncertain behavior of brain, infratentorial Mass documented below the tentorium cerebelli (cerebellum, brain stem)
D43.2 Neoplasm of uncertain behavior of brain, unspecified Location within brain not specified in documentation; use only when D43.0 or D43.1 cannot be supported
D43.3 Neoplasm of uncertain behavior of cranial nerves Mass with uncertain behavior involving cranial nerves (e.g., optic or chiasmal glioma); excludes peripheral/autonomic nerve tumors, which use D48.2
D43.4 Neoplasm of uncertain behavior of spinal cord Mass with uncertain behavior specifically involving the spinal cord
D43.8 Neoplasm of uncertain behavior of other specified parts of CNS Uncertain behavior neoplasm at another specified CNS site not covered by D43.0-D43.4
D43.9 Neoplasm of uncertain behavior of CNS, unspecified CNS involvement without brain or spinal cord specification; broader than D43.2

G44.89 follows the same pattern in a different chapter. A specified clinical presentation maps to one code, while an unspecified one maps to another, and coders cannot treat the two as interchangeable. The same principle applies to I5A, where documentation must support the specific diagnosis before the code replaces a broader placeholder.

Approximate synonyms and clinical terminology for D43.2

Physicians and radiologists rarely write “neoplasm of uncertain behavior of brain, unspecified” verbatim in notes. Coders must recognize the following accepted clinical synonyms as documentation that supports D43.2:

  • Brain mass, unspecified
  • Cerebral mass of uncertain behavior
  • Intracranial mass, uncertain behavior
  • Intracranial neoplasm of uncertain nature
  • Brain tumor of uncertain behavior
  • Neoplasm of uncertain or unknown behavior of brain
  • Brain neoplasm, behavior unclassified
  • Uncertain behavior brain lesion (when behavior is documented; not to be confused with a lesion of unspecified behavior)

The distinction between “uncertain behavior” and “unspecified behavior” carries direct reimbursement weight, not just wording. Uncertain behavior means pathology or imaging has been reviewed and the behavior cannot be classified as malignant or benign. Unspecified behavior means no such determination has been attempted or documented.

That difference maps to two different code groups in ICD-10-CM. The CDC/NCHS ICD-10-CM web tool allows coders to search by synonym to confirm correct code assignment.

Pro Tip

When a radiology report uses the phrase ‘cannot exclude malignancy’ or ‘indeterminate mass’ without a tissue diagnosis, query the attending physician for clarification before assigning D43.2. The code requires documented clinical intent that the behavior is uncertain, not simply unexamined.

When to use D43.2 vs other brain neoplasm codes

Selecting the wrong behavior category is the highest-risk coding error in this space. The table below maps the four main behavior categories to their correct ICD-10-CM code ranges for brain neoplasms.

Clinical scenario Correct code range Notes
Primary malignant brain tumor confirmed C71.x Histological confirmation of malignancy required; specify lobe or site (C71.0-C71.9)
Metastatic (secondary) malignant brain tumor C79.31 Also code the primary site malignancy; used for documented metastatic spread to brain
Benign brain tumor confirmed D33.x Specify site (D33.0 supratentorial, D33.1 infratentorial, D33.2 unspecified)
Uncertain behavior documented by clinician or pathology D43.x Use D43.0, D43.1, or D43.2 depending on documented location; D43.2 when site unspecified
No behavior determination attempted or documented D49.6 Neoplasm of unspecified behavior of brain; use only when the record is truly silent on behavior classification

D43.2 requires that a clinician or pathologist has made a determination that the behavior is uncertain. D49.6 applies when no such assessment is documented. Using D49.6 when the record contains language like “uncertain malignant potential” or “borderline tumor” is a coding error with audit risk.

Per the AAPC ICD-10-CM code reference, D43.2 is a more specific and preferred code wherever the clinical documentation supports it.

Documentation requirements for ICD-10 Code D43.2

Claims for D43.2 are defensible when the medical record contains clear, physician-attributable language supporting uncertain behavior. The following elements should be present before this code is assigned.

  • Pathology or imaging language: A formal pathology report, MRI/CT radiology interpretation, or neurosurgical note explicitly using terms such as “uncertain behavior,” “indeterminate,” “borderline malignancy,” or “cannot be classified as benign or malignant.”
  • Physician attestation: The treating or consulting physician’s documentation must reflect the uncertain nature of the neoplasm. Radiologist impression alone, without attending sign-off, may not be sufficient for all payers.
  • Histology status documented: If biopsy results are pending, the code may be provisional. Once histological confirmation changes the behavior classification, the code should be updated to the appropriate C71.x, D33.x, or remain D43.x depending on findings.
  • Site specificity addressed: Even if D43.2 is used due to unspecified site, the record should reflect that site documentation was genuinely unavailable, not simply omitted.
  • Absence of conflicting documentation: No other note in the record should definitively classify the tumor as malignant or benign while D43.2 is assigned, as conflicting entries create audit vulnerability.

Practices using a structured clinical documentation system can tag uncertain-behavior diagnoses at the point of care, making coder-physician queries more efficient. For practices handling sensitive patient health data alongside coding workflows, maintaining HIPAA-compliant documentation workflows is a parallel requirement.

Well-structured digital intake forms can also standardize how neoplasm history and imaging results are captured before a coder reviews the record.

Comprehensive EMR & patient record management
Comprehensive EMR & patient record management

Commonly paired ICD-10 codes with D43.2

D43.2 is rarely the only code on a claim. The table below shows codes frequently reported alongside it, drawn from standard clinical scenarios for brain mass management.

Code Description Usage context
R90.0 Intracranial space-occupying lesion Often paired when imaging identifies the mass before histological confirmation; documents the radiological finding alongside the diagnosis
G89.3 Neoplasm related pain (acute or chronic) When the patient presents with pain attributable to the brain mass; sequence D43.2 first as the underlying condition
G40.x Epilepsy and recurrent seizures Mass-related seizure activity documented; code the seizure type specifically under G40; D43.2 as etiology
R51.9 Headache, unspecified Symptom code; used when headache is the presenting complaint and is attributable to the mass
Z86.011 Personal history of benign neoplasm of brain Prior history context; may appear on follow-up encounters after a previously benign tumor is now assessed as uncertain behavior on re-imaging

Note on R90.0: this pairing is documented in ICD-10-CM clinical scenario guidance, but the sequencing depends on the primary reason for the encounter. When the encounter is specifically to assess the neoplasm, D43.2 sequences first. The HIPAA compliance checklist for primary care practices is a useful reference for understanding paired-code submission requirements within HIPAA-covered transactions.

MS-DRG assignment and reimbursement context for D43.2

For inpatient encounters, D43.2 maps to MS-DRG groupings under CMS’s MS-DRG v43.0 (updated to v43.1 effective April 1, 2026) Definitions Manual. The specific DRG assignment depends on whether a major procedure was performed and on the patient’s comorbidities and complications (CC/MCC status).

DRG context Details
DRG grouper version CMS MS-DRG v43.0, updated to v43.1 effective April 1, 2026; verify annually as DRG groupings update each October
Typical DRG range D43.2 as principal diagnosis maps to the nervous system neoplasm DRG cluster (DRGs 054-055); exact assignment requires the full DRG grouper with procedure codes entered
CC/MCC impact Comorbidities and complications shift the DRG tier; accurate secondary code selection (e.g. G40.x, R90.0) directly affects the reimbursement weight
Outpatient context D43.2 is valid for outpatient/HOPD claims; no MS-DRG grouping applies; reimbursement follows APC assignment or fee-schedule rules
Payer variation Commercial payer DRG weights and payment rates vary; always verify against the specific payer contract

Inpatient teams should run D43.2 through a DRG grouper with all secondary diagnoses and procedure codes before finalizing the claim. Relying on an estimated DRG without entering the full encounter data is a common cause of underpayment.

Practices managing complex neurology billing alongside broader operational workflows benefit from patient data security tools that keep sensitive diagnostic records protected throughout the billing cycle.

Manage complex diagnostic coding workflows in one place

Pabau's claims management software helps neurology and specialty clinics attach accurate ICD-10 diagnosis codes, track claim status, and reduce rework. See how coding teams use Pabau to cut billing errors and improve first-pass acceptance rates.

Pabau claims management and ICD-10 coding workflow dashboard

Coding tips and common errors for D43.2

D43.2 generates more audit queries than most neoplasm codes because the “uncertain behavior” designation is clinically nuanced. These are the most frequent coding pitfalls:

  • Using D49.6 when the record specifies uncertain behavior: If the physician or pathologist has documented that the behavior is uncertain, D43.2 is the correct code. D49.6 is only appropriate when the record is genuinely silent on behavior classification. Substituting D49.6 for D43.2 when better documentation is available undercodes the encounter and can trigger medical necessity denials.
  • Assigning D43.2 without any supporting documentation: The code requires a clinical basis. A scan showing “a lesion” with no behavior characterization in any note does not support D43.2. Query the clinician before assigning.
  • Failing to update the code post-biopsy: D43.2 is appropriate during the diagnostic workup period. Once histology confirms malignancy (C71.x) or benign status (D33.x), the code should be updated on subsequent encounters. Continuing to use D43.2 after a definitive pathology result is a coding error.
  • Selecting D43.2 instead of D43.0 or D43.1 when location is documented: If the operative report or MRI clearly identifies the mass as supratentorial or infratentorial, a more specific sibling code applies. D43.2 is for genuinely unspecified site only.
  • Ignoring sequencing rules with R90.0: R90.0 documents the imaging finding; it does not replace the neoplasm diagnosis code. When both are present, the reason for the encounter determines principal diagnosis sequencing.

Reducing these errors at scale requires a documentation infrastructure that supports coder-physician queries in real time. Teams using claims management software with integrated clinical notes can flag uncertain-behavior diagnoses during note creation rather than at the billing stage.

For practices evaluating broader practice management software with coding support, the ICD-10 code D43.2 workflow is a useful test case for how well the platform handles diagnosis-level documentation requirements.

Practices in behavioral health run into a similar specificity challenge when psychiatric or neurodevelopmental diagnoses lack a documented severity or subtype.

The same specificity principle applies elsewhere in medical coding. CPT code 71271 and ICD-10 code T31.94 both require documentation precise enough to rule out a vaguer, catch-all code.

Fully Integrated with Pabau Billing
Fully Integrated with Pabau Billing

Pro Tip

Run a quarterly audit of all claims where D49.6 was submitted as principal diagnosis alongside any brain imaging CPT code. If physician documentation in those records contains language like ‘uncertain’ or ‘indeterminate,’ you have miscoded candidates. Reclassifying to D43.2 where supported can recover revenue and reduces audit risk.

Conclusion

Getting ICD-10 Code D43.2 right comes down to one clinical question. Does the record document that the behavior is uncertain, or is it simply unknown? That distinction separates D43.2 from D49.6, determines which MS-DRG tier an inpatient claim lands in, and defines the audit defensibility of the encounter.

Using D43.2 correctly means verifying behavior documentation, checking whether a more specific sibling code (D43.0 or D43.1) is supported by anatomical details, and updating the code once histology returns a definitive answer.

Pabau’s practice management software supports diagnosis code accuracy by keeping clinical documentation, coder workflows, and billing in a single environment. To see how coding teams use Pabau to reduce claim rework, book a demo.

Continue your research

Continue your research

Curious how documentation specificity plays out elsewhere in ICD-10-CM? M14.88 shows the same coder-versus-clinician judgment call applied to joint disease coding.

Coding for neurostimulator hardware alongside a brain diagnosis? L8680 covers the implantable electrode billing side of neurological procedures.

Want a broader clinical documentation reference for primary care? Blood pressure monitoring walks through the documentation standards behind one of the most common primary care measurements.

Frequently Asked Questions

What does ICD-10 Code D43.2 mean?

ICD-10 Code D43.2 is a billable ICD-10-CM diagnosis code for a neoplasm of uncertain behavior of the brain, unspecified. It describes a brain mass or tumor whose biological behavior cannot be definitively classified as malignant, benign, or in-situ based on available pathology or imaging data. The code is valid for all HIPAA-covered transactions under the 2026 ICD-10-CM edition, effective October 1, 2025.

Is D43.2 a billable ICD-10-CM code?

Yes. D43.2 is a specific, billable ICD-10-CM code valid for diagnosis reporting and reimbursement submissions. It is accepted in all HIPAA-covered transactions and is included in the 2026 edition of the ICD-10-CM tabular list, as confirmed by CMS code files and the AAPC code reference.

What is the difference between D43.0, D43.1, and D43.2?

All three codes describe a neoplasm of uncertain behavior of the brain, but differ by anatomical location. D43.0 applies to supratentorial neoplasms (cerebral hemispheres, frontal, parietal, temporal, and occipital lobes). D43.1 applies to infratentorial neoplasms (cerebellum, brain stem). D43.2 is used only when the documentation does not specify whether the location is supratentorial or infratentorial. Always select the most specific code the record supports.

When should D43.2 be used instead of D49.6?

Use D43.2 when a clinician or pathologist has affirmatively documented that the brain neoplasm’s behavior is uncertain, for example using terms like “uncertain malignant potential,” “borderline tumor,” or “indeterminate behavior.” Use D49.6 only when the record is completely silent on behavior classification and no determination has been attempted. Assigning D49.6 when the record actually contains uncertain-behavior language is a coding error with audit risk.

What MS-DRG does D43.2 map to?

Under CMS MS-DRG v43.0 (updated to v43.1 effective April 1, 2026), D43.2 as principal diagnosis maps to the nervous system neoplasm DRG cluster (DRGs 054-055), with the specific DRG determined by whether a qualifying procedure was performed and by the presence of comorbidities or complications (CC/MCC). The exact DRG assignment requires running the full encounter through a certified DRG grouper. DRG groupings are updated annually each October, so always verify against the current version.

What ICD-10 codes are commonly used with D43.2?

R90.0 (intracranial space-occupying lesion) is frequently paired when imaging identifies the mass before histological confirmation. G89.3 (neoplasm-related pain), G40.x (seizures), and R51.9 (headache) may also appear depending on the clinical presentation. Sequencing depends on the primary reason for the encounter; when the purpose is to evaluate or treat the neoplasm, D43.2 sequences first.

×